Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2017, Article ID 1206015, 7 pages
https://doi.org/10.1155/2017/1206015
Research Article

In Vitro and In Vivo Effects of Norathyriol and Mangiferin on α-Glucosidase

1Yunnan University of Traditional Chinese Medicine, Kunming 650500, China
2Institute of Drug Discovery & Development, Kunming Pharmaceutical Corporation, Kunming 650106, China

Correspondence should be addressed to Jian-Hua Shang; moc.361@uwoayhjs and Zhao-Xiang Yang; moc.361@ykxzgnay

Received 18 August 2016; Accepted 14 November 2016; Published 10 January 2017

Academic Editor: Andrei Surguchov

Copyright © 2017 Zhi-Long Shi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Borges de Melo, A. da Silveira Gomes, and I. Carvalho, “α- and β-glucosidase inhibitors: chemical structure and biological activity,” Tetrahedron, vol. 62, no. 44, pp. 10277–10302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. T. K. Girish, V. M. Pratape, and U. J. S. Prasada Rao, “Nutrient distribution, phenolic acid composition, antioxidant and alpha-glucosidase inhibitory potentials of black gram (Vigna mungo L.) and its milled by-products,” Food Research International, vol. 46, no. 1, pp. 370–377, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Casirola and R. P. Ferraris, “α-glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice,” Metabolism, vol. 55, no. 6, pp. 832–841, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Muruganandan, K. Srinivasan, S. Gupta, P. K. Gupta, and J. Lal, “Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats,” Journal of Ethnopharmacology, vol. 97, no. 3, pp. 497–501, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Sanugul, T. Akao, Y. Li, N. Kakiuchi, N. Nakamura, and M. Hattori, “Isolation of a human intestinal bacterium that transforms mangiferin to norathyriol and inducibility of the enzyme that cleaves a C-glucosyl bond,” Biological and Pharmaceutical Bulletin, vol. 28, no. 9, pp. 1672–1678, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. C. W. Choi, Y. H. Choi, M.-R. Cha et al., “Yeast α-glucosidase inhibition by isoflavones from plants of leguminosae as an in vitro alternative to acarbose,” Journal of Agricultural and Food Chemistry, vol. 58, no. 18, pp. 9988–9993, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Rivera-Chávez, M. González-Andrade, M. Del Carmen González, A. E. Glenn, and R. Mata, “Thielavins A, J and K: α-glucosidase inhibitors from MEXU 27095, an endophytic fungus from Hintonia latiflora,” Phytochemistry, vol. 94, pp. 198–205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Wu, J. Shen, P. He et al., “The α-glucosidase inhibiting isoflavones isolated from belamcanda chinensis leaf extract,” Records of Natural Products, vol. 6, no. 2, pp. 110–120, 2012. View at Google Scholar · View at Scopus
  10. R. Tundis, M. R. Loizzo, and F. Menichini, “Natural products as α-amylase and α-Glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update,” Mini-Reviews in Medicinal Chemistry, vol. 10, no. 4, pp. 315–331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Liu, L. Ma, W.-H. Chen, H. Park, Z. Ke, and B. Wang, “Binding mechanism and synergetic effects of xanthone derivatives as noncompetitive α-glucosidase inhibitors: a theoretical and experimental study,” The Journal of Physical Chemistry B, vol. 117, no. 43, pp. 13464–13471, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. M. De Veciana, C. A. Major, M. A. Morgan et al., “Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy,” New England Journal of Medicine, vol. 333, no. 19, pp. 1237–1241, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Wang, J. Yan, Y. Niu et al., “Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase,” Pharmaceutical Biology, vol. 52, no. 1, pp. 68–73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Hsun-Wei Huang, G. Peng, G. Qian Li, J. Yamahara, B. D. Roufogalis, and Y. Li, “Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-α,” Toxicology and Applied Pharmacology, vol. 210, no. 3, pp. 225–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Ding, Y. Zhang, C. Xu et al., “Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B,” Diabetologia, vol. 57, no. 10, pp. 2145–2154, 2014. View at Publisher · View at Google Scholar · View at Scopus